Hi GG,
Specific question/s for the AGM:-
"Cavatak has continually delivered excellent results and a superb safety profile either as a monotherapy or in combination.
Pharmaceutical Companies will no doubt be totally aware of the clinical results.
Has interest been shown?... if so, by whom?... to what extent?
Thank you GG.... I look forward to reading your experience.
- Forums
- ASX - By Stock
- VLA
- Ann: New Data at SITC Meeting. Further Studies Announced
Ann: New Data at SITC Meeting. Further Studies Announced, page-86
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online